Fig. 5

Absorbed dose to the bone marrow over the course of all received treatments for all patients (black curve) and patients with skeletal metastases (orange curve). No significant change in absorbed dose for each treatment was observed in either patient subgroup. The solid curves represent the median and the dashed lines represent the 25 and 75 percentiles, respectively. Grey lines show the individual values for each patient. Only three patients received more than five treatments—those data points are not shown in this graph